Video

Educated Patient® Skin Cancer Summit: June 26, 2021

Author(s):

CURE Media Group

View the full CURE Educated Patient Skin Cancer Summit on demand.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of two doctors and text.
Imiage of two doctors with text.
Image of two doctors and text.
Image of patient and doctor.
Image of two doctors with text.
image of gerds
Image of 2 doctors and text.
Image of two doctors and text.
Image of thumbnail.
Image of doctor.
Related Content
Image of two doctors with text.
June 22nd 2025

Experts Impart Notable Information and Updates for Those With Blood Cancers

Dr. Joshua K. Sabari Dr. Nausheen Ahmed
The 2025 ASCO Annual Meeting brought many different updates to light in the realm of hematological malignancies, including multiple myeloma and lymphoma.
CURE Cancer Horizons logo
February 26th 2024

FDA Approvals from February 2024

Alex Biese Brielle Benyon
February brought in multiple FDA approvals in the oncology space. Here’s an overview of some of the most recent ones.
Image of breast.
June 19th 2025

Breaking Down the Impact of SERENA-6 for Some With Breast Cancer

Ryan Scott
Dr. Joshua K. Sabari and Dr. Julia E. McGuinness discussed the SERENA-6 trial and its outcomes for patients with ESR1-mutated HR+/HER2— breast cancer.
Top Cancer Headlines from 2023
January 2nd 2024

Top Cancer Headlines from 2023

Alex Biese Brielle Benyon
From Jimmy Buffett's death to the chemo shortage and cannabis use in cancer care, here is a look back at some of our most popular oncology stories from 2023.
Image of hands.
June 18th 2025

The Person Behind Their Diagnosis: Understanding the Patient

Ryan Scott
Dr. Joshua Sabari and Jackie Herigodt discuss the Imerman Angels organization and the importance of recognizing the person behind their cancer diagnosis.
image of lung scan.
June 16th 2025

Rybrevant Combo Improves Lung Cancer Outcomes After Tagrisso Failure

Ariana Pelosci
Rybrevant plus chemotherapy improved response and delayed disease progression for patients with EGFR-mutated non–small cell lung cancer after Tagrisso.